Patient characteristics
| Patient ID . | % CD34 . | BM/PB . | FLT3 ITD . | Karyotype . | Risk group . |
|---|---|---|---|---|---|
| 1 | 70 | PB | − | +3q;−7;−10 | Poor |
| 2 | 26 | PB | − | bcr-abl, inv16 | Poor |
| 3 | 5 | BM | + | Normal | Intermediate |
| 4 | 70 | BM | − | 5q−; trisomy 6 | Poor |
| 5 | 86 | BM | + | Normal | Intermediate |
| 6 | 54 | BM | + | Normal | Intermediate |
| 7 | 30 | BM | − | Normal | Intermediate |
| 8 | 91 | BM | − | Normal | Intermediate |
| 9 | 85 | PB | + | Normal | Intermediate |
| Patient ID . | % CD34 . | BM/PB . | FLT3 ITD . | Karyotype . | Risk group . |
|---|---|---|---|---|---|
| 1 | 70 | PB | − | +3q;−7;−10 | Poor |
| 2 | 26 | PB | − | bcr-abl, inv16 | Poor |
| 3 | 5 | BM | + | Normal | Intermediate |
| 4 | 70 | BM | − | 5q−; trisomy 6 | Poor |
| 5 | 86 | BM | + | Normal | Intermediate |
| 6 | 54 | BM | + | Normal | Intermediate |
| 7 | 30 | BM | − | Normal | Intermediate |
| 8 | 91 | BM | − | Normal | Intermediate |
| 9 | 85 | PB | + | Normal | Intermediate |
BM indicates bone marrow; PB, peripheral blood; and ITD, internal tandem duplication.